Authors assessed the antitumor activity of curcumin using three different osteosarcoma cell lines (U2OS, SaOS-2, and MG-63), to see whether downregulation of Notch-1 is critical in curcumin-induced inhibition of proliferation and invasion in osteosarcoma cells. This evidence concerns the gene NOTCH1 and osteosarcoma.